PVR and neoplasm: In particular, CD155 once up-regulated on different types of tumor cells is recognized by a group of receptors expressed on T and NK cells: The activating receptor DNAM-1 (CD226) and the inhibitory receptors TIGIT and TACTILE (CD96) [22,23,37].